Published in J Acquir Immune Defic Syndr on August 01, 2002
The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health (2003) 3.61
Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol (2008) 2.27
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health (2008) 1.33
Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors. Drug Alcohol Depend (2011) 1.22
Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health (2005) 1.18
Methamphetamine dependence and human immunodeficiency virus risk behavior. J Subst Abuse Treat (2008) 1.16
A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Soc Sci Med (2008) 1.13
Opportunities to learn and barriers to change: crack cocaine use in the Downtown Eastside of Vancouver. Harm Reduct J (2008) 1.04
Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis (2012) 1.04
Fumando la piedra: emerging patterns of crack use among Latino immigrant day laborers in New Orleans. J Immigr Minor Health (2010) 1.02
Male injection drug users try new drugs following U.S. deportation to Tijuana, Mexico. Drug Alcohol Depend (2011) 0.95
Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B virus infection in the Women's Interagency HIV Study. Clin Infect Dis (2004) 0.92
Sexual risk and HIV infection among drug users in New York City: a pilot study. Subst Use Misuse (2011) 0.91
Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users. Epidemiol Infect (2005) 0.90
The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary. Drug Alcohol Depend (2008) 0.89
Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Int J Drug Policy (2007) 0.88
Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians. J Addict Med (2012) 0.88
A needle in the haystack - the dire straits of needle exchange in Hungary. BMC Public Health (2016) 0.88
A trial to reduce hepatitis C seroincidence in drug users. J Addict Dis (2009) 0.86
Bloodborne viral hepatitis infections among drug users: the role of vaccination. Int J Environ Res Public Health (2009) 0.85
High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia. BMC Public Health (2010) 0.85
HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, China. PLoS One (2012) 0.84
Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors. Epidemiol Infect (2006) 0.84
Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users. Vaccine (2011) 0.83
Risky Sexual Behaviors among a Sample of Gang-identified Youth in Los Angeles. J Equity Health (2009) 0.81
Patterns, determinants and barriers of health and social service utilization among young urban crack users in Brazil. BMC Health Serv Res (2013) 0.81
The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Public Health (Oxf) (2012) 0.80
Aberrant disgust responses and immune reactivity in cocaine-dependent men. Biol Psychiatry (2013) 0.80
A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada. Harm Reduct J (2014) 0.80
Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users. Am J Public Health (2015) 0.79
Hepatitis A Virus among Drug Users and the Role of Vaccination: A Review. Front Psychiatry (2012) 0.78
High prevalence of HIV-1 CRF01_AE viruses among female commercial sex workers residing in Surabaya, Indonesia. PLoS One (2013) 0.77
The association between social marginalisation and the injecting of alcohol amongst IDUs in Budapest, Hungary. Int J Drug Policy (2011) 0.75
HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women. Addiction (2005) 0.75
Predictors of Illicit Drug Use Among Prisoners. Subst Use Misuse (2016) 0.75
Sexual HIV/HSV-2 risk among drug users in New York City: an HIV testing and counseling intervention. Subst Use Misuse (2013) 0.75
Public opinions about supervised smoking facilities for crack cocaine and other stimulants. Subst Abuse Treat Prev Policy (2016) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The social structural production of HIV risk among injecting drug users. Soc Sci Med (2005) 7.78
Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health (2006) 4.85
The differential effects of face-to-face and computer interview modes. Am J Public Health (2002) 4.13
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS (2006) 3.55
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol (2003) 3.29
A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr (2002) 3.20
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis (2011) 3.13
Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction (2004) 2.97
Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS (2005) 2.91
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr (2004) 2.90
Alternatives to the randomized controlled trial. Am J Public Health (2008) 2.85
HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health (2005) 2.62
Transmission and prevention of HIV and sexually transmitted infections in war settings: implications for current and future armed conflicts. AIDS (2002) 2.54
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS (2007) 2.52
Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology (2004) 2.52
The clonality of Staphylococcus aureus nasal carriage. J Infect Dis (2005) 2.39
Urging others to be healthy: "intravention" by injection drug users as a community prevention goal. AIDS Educ Prev (2004) 2.31
Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol (2008) 2.27
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health (2008) 2.23
A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. J Acquir Immune Defic Syndr (2002) 2.16
Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy (2008) 2.15
The psychology of preventing AIDS among intravenous drug users. A social learning conceptualization. Am Psychol (1988) 2.12
Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study. PLoS One (2013) 2.06
Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr (2002) 1.97
Emerging future issues in HIV/AIDS social research. AIDS (2006) 1.95
Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr (2006) 1.88
'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction (2007) 1.85
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (2002) 1.83
Staphylococcus aureus ST398, New York City and Dominican Republic. Emerg Infect Dis (2009) 1.83
Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr (2002) 1.78
Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clin Infect Dis (2007) 1.77
Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. Int J Drug Policy (2006) 1.74
Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend (2006) 1.69
Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr (2005) 1.69
Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis (2002) 1.63
Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach. Am J Public Health (2014) 1.62
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS One (2013) 1.61
HIV prevalence rates among men who have sex with men in the southern United States: population-based estimates by race/ethnicity. AIDS Behav (2011) 1.59
Statewide estimation of racial/ethnic populations of men who have sex with men in the U.S. Public Health Rep (2011) 1.58
The environment as an unrecognized reservoir for community-associated methicillin resistant Staphylococcus aureus USA300: a case-control study. PLoS One (2011) 1.57
HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health (2003) 1.55
Contextual determinants of condom use among female sex exchangers in East Harlem, NYC: an event analysis. AIDS Behav (2006) 1.54
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health (2004) 1.49
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health (2009) 1.49
HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy (2007) 1.48
Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend (2007) 1.47
Incarceration, sex with an STI- or HIV-infected partner, and infection with an STI or HIV in Bushwick, Brooklyn, NY: a social network perspective. Am J Public Health (2011) 1.46
Racial/ethnic disparities in injection drug use in large US metropolitan areas. Ann Epidemiol (2005) 1.43
Alcohol and HIV sexual risk behaviors among injection drug users. Drug Alcohol Depend (2008) 1.41
Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat (2003) 1.41
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. Addiction (2007) 1.41
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend (2008) 1.41
A nationwide survey of hepatitis C services provided by drug treatment programs. J Subst Abuse Treat (2002) 1.40
HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS (2005) 1.40
An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men. J Urban Health (2004) 1.38
Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (2012) 1.38
HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst Use Misuse (2011) 1.34
Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health (2008) 1.33
Unprotected anal intercourse and sexually transmitted diseases in high-risk heterosexual women. Am J Public Health (2010) 1.31
Correlates of HIV status among injection drug users in a border region of southern China and northern Vietnam. J Acquir Immune Defic Syndr (2005) 1.31
Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction (2003) 1.30
An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav (2013) 1.27
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend (2007) 1.26
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health (2004) 1.26
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med (2009) 1.23
Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors. Health Place (2011) 1.23
Harnessing the power of social networks to reduce HIV risk. Focus (2005) 1.23
Strategies to avoid opiate withdrawal: implications for HCV and HIV risks. Int J Drug Policy (2009) 1.23
Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas. Am J Public Health (2006) 1.22
HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend (2010) 1.21
Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia. J Urban Health (2010) 1.21
Reconsidering the internet as an HIV/STD risk for men who have sex with men. AIDS Behav (2010) 1.21
The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary. AIDS Educ Prev (2004) 1.20
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis (2012) 1.20
Diffusion of the D.A.R.E and syringe exchange programs. Am J Public Health (2006) 1.20
Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav (2013) 1.20
Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need. J Urban Health (2009) 1.19
Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev (2010) 1.19
HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health (2007) 1.19
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. J Urban Health (2008) 1.18
How can hepatitis C be prevented in the long term? Int J Drug Policy (2007) 1.18